Zobrazeno 1 - 7
of 7
pro vyhledávání: '"MESH: Pyridazines"'
Autor:
Christine Katlama, Lambert Assoumou, Marc-Antoine Valantin, Cathia Soulié, Esteban Martinez, Lydie Béniguel, Olivier Bouchaud, François Raffi, Jean-Michel Molina, Soraya Fellahi, Gilles Peytavin, Anne-Geneviève Marcelin, Sami Kolta, Jacqueline Capeau, Severine Gibowski, Fanny Cardon, Jacques Reynes, Dominique Costagliola
Publikováno v:
Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2020, 75 (12), pp.3699-3700. ⟨10.1093/jac/dkaa341⟩
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2020, 75 (12), pp.3699-3700. ⟨10.1093/jac/dkaa341⟩
International audience
Autor:
Boris Barbour, Antonin Blot
Publikováno v:
Nature Neuroscience
Nature Neuroscience, Nature Publishing Group, 2014, 17 (2), pp.289-295. ⟨10.1038/nn.3624⟩
Nature Neuroscience, 2014, 17 (2), pp.289-295. ⟨10.1038/nn.3624⟩
Nature Neuroscience, Nature Publishing Group, 2014, 17 (2), pp.289-295. ⟨10.1038/nn.3624⟩
Nature Neuroscience, 2014, 17 (2), pp.289-295. ⟨10.1038/nn.3624⟩
International audience; Excitatory synaptic activity in the brain is shaped and balanced by inhibition. Because inhibition cannot propagate, it is often recruited with a synaptic delay by incoming excitation. Cerebellar Purkinje cells are driven by l
Autor:
Fagard, Catherine, Colin, Céline, Charpentier, Charlotte, Rami, Agathe, Jacomet, Christine, Yeni, Patrick, Vittecoq, Daniel, Katlama, Christine, Molina, Jean-Michel, Descamps, Diane, Chêne, Geneviève, Yazdanpanah, Yazdan, Michelet, Christian
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes
Journal of Acquired Immune Deficiency Syndromes, Lippincott, Williams & Wilkins, 2012, 59 (5), pp.489-93. ⟨10.1097/QAI.0b013e31824bb720⟩
Journal of Acquired Immune Deficiency Syndromes-JAIDS
Journal of Acquired Immune Deficiency Syndromes-JAIDS, 2012, 59 (5), pp.489-93. ⟨10.1097/QAI.0b013e31824bb720⟩
Journal of Acquired Immune Deficiency Syndromes, Lippincott, Williams & Wilkins, 2012, 59 (5), pp.489-93. ⟨10.1097/QAI.0b013e31824bb720⟩
Journal of Acquired Immune Deficiency Syndromes-JAIDS
Journal of Acquired Immune Deficiency Syndromes-JAIDS, 2012, 59 (5), pp.489-93. ⟨10.1097/QAI.0b013e31824bb720⟩
International audience; Among 103 patients with multidrug-resistant HIV who initiated raltegravir, etravirine, and darunavir/ritonavir-containing regimen in the ANRS 139 TRIO trial, 100 participated in extended follow-up and continued study treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::135ff9781de79fa9308a620e8a93fc11
https://hal.archives-ouvertes.fr/hal-00875207
https://hal.archives-ouvertes.fr/hal-00875207
Autor:
Marc Labrunee, Nicolas Franchitto, Michel Galinier, Atul Pathak, Jean-Michel Senard, Charlotte Trouillet, Fabien Despas
Publikováno v:
Acute Cardiac Care
Acute Cardiac Care, 2010, 12 (1), pp.25-30. ⟨10.3109/17482940903434077⟩
Acute Cardiac Care, Taylor & Francis, 2010, 12 (1), pp.25-30. ⟨10.3109/17482940903434077⟩
Acute Cardiac Care, 2010, 12 (1), pp.25-30. ⟨10.3109/17482940903434077⟩
Acute Cardiac Care, Taylor & Francis, 2010, 12 (1), pp.25-30. ⟨10.3109/17482940903434077⟩
International audience; Levosimendan is a new inodilatory agent with calcium sensitizing activity. A major concern regarding the use of inotropic agent in heart failure is their effect on the sympathetic tone. This effect could explain increase in sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0e3b4f152fd37a0de64331ae324d906
https://www.hal.inserm.fr/inserm-00504954
https://www.hal.inserm.fr/inserm-00504954
Publikováno v:
Neuropharmacology
Neuropharmacology, 2009, 56 (8), pp.1106-15. ⟨10.1016/j.neuropharm.2009.03.009⟩
Neuropharmacology, Elsevier, 2009, 56 (8), pp.1106-15. ⟨10.1016/j.neuropharm.2009.03.009⟩
Neuropharmacology, 2009, 56 (8), pp.1106-15. ⟨10.1016/j.neuropharm.2009.03.009⟩
Neuropharmacology, Elsevier, 2009, 56 (8), pp.1106-15. ⟨10.1016/j.neuropharm.2009.03.009⟩
International audience; Numerous studies, focused on the hypothalamus, have recently implicated endocannabinoids (EC) as orexigenic factors in the central control of food intake. However, the EC system is also highly expressed in the hindbrain autono
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::413864ac0e119003d01823190d898cf0
https://hal.science/hal-00417358
https://hal.science/hal-00417358
Autor:
Duittoz, Anne, Martin, R
Publikováno v:
Journal of Experimental Biology
Journal of Experimental Biology, The Company of Biologists, 1991, 159, pp.149-64
Journal of Experimental Biology, The Company of Biologists, 1991, 159, pp.149-64
1. In a previous study, it was shown that the potency order for two arylamino-pyridazine derivatives, SR95531 and SR95103, was different in Ascaris suum when compared to vertebrate preparations. SR95531, the most potent analogue at the vertebrate GAB
Autor:
Jean-Yves Springael, Didier Rognan, Marc Parmentier, Jean-Luc Galzi, Esther Kellenberger, Muriel Hachet-Haas
Publikováno v:
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, American Chemical Society, 2007, 50 (6), pp.1294-303. ⟨10.1021/jm061389p⟩
Journal of Medicinal Chemistry, American Chemical Society, 2007, 50 (6), pp.1294-1303. ⟨10.1021/jm061389p⟩
Journal of Medicinal Chemistry, American Chemical Society, 2007, 50 (6), pp.1294-303. ⟨10.1021/jm061389p⟩
Journal of Medicinal Chemistry, American Chemical Society, 2007, 50 (6), pp.1294-1303. ⟨10.1021/jm061389p⟩
International audience; A three-dimensional model of the chemokine receptor CCR5 has been built to fulfill structural peculiarities of its alpha-helix bundle and to distinguish known CCR5 antagonists from randomly chosen drug-like decoys. In silico s